Bionomics Limited
NASDAQ:BNOX
0.38 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.02 | 0.26 | 0 | 0.05 | 3.82 | 8.794 | 20.789 | 14.326 |
| Cost of Revenue
| 0.434 | 13.063 | 11.046 | 4.321 | 4.022 | 8.516 | 18.686 | 18.618 | 18.453 |
| Gross Profit
| -0.434 | -12.631 | -6.865 | -3.625 | -1.957 | -3.345 | -9.892 | 2.171 | -4.127 |
| Gross Profit Ratio
| 0 | -29.193 | -1.642 | -5.209 | -0.948 | -0.647 | -1.125 | 0.104 | -0.288 |
| Reseach & Development Expenses
| 9,417.785 | 19.61 | 16 | 5.76 | 5.83 | 8.98 | 18.686 | 18.618 | 18.453 |
| General & Administrative Expenses
| 8,474.591 | 5.752 | 5.108 | 3.279 | 2.533 | 4.683 | 6.861 | 4.401 | 5.607 |
| Selling & Marketing Expenses
| 0 | 0.147 | 0.181 | 0.954 | 0.815 | 0.851 | 1.049 | 1.994 | 2.26 |
| SG&A
| 8,474.591 | 8.86 | 7.66 | 5.65 | 4.85 | 9.35 | 7.909 | 6.395 | 7.867 |
| Other Expenses
| 0 | 0 | 0.007 | 0.203 | 0.2 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 17,892.376 | 32 | 21.61 | 11.92 | 9.06 | 19.18 | 8.437 | 6.368 | 8.281 |
| Operating Income
| -17,892.376 | -31.97 | -21.34 | -11.92 | -9.01 | -15.36 | -17.801 | -4.224 | -11.994 |
| Operating Income Ratio
| 0 | -42.826 | -2.906 | -11.073 | -2.502 | -1.717 | -2.024 | -0.203 | -0.837 |
| Total Other Income Expenses Net
| 2,312.89 | -0.08 | -0.61 | 3.04 | 2.99 | 5.45 | -1.625 | -0.562 | -0.912 |
| Income Before Tax
| -15,579.486 | -32.05 | -21.95 | -8.88 | -6.03 | -9.91 | -19.426 | -4.786 | -12.906 |
| Income Before Tax Ratio
| 0 | -49.343 | -3.625 | -9.573 | -2.014 | -1.436 | -2.209 | -0.23 | -0.901 |
| Income Tax Expense
| -87.32 | -0.21 | -0.19 | -0.19 | -0.21 | -0.24 | 0.859 | 0.402 | 0.545 |
| Net Income
| -15,492.166 | -31.85 | -21.76 | -8.7 | -7.12 | -9.67 | -18.567 | -5.188 | -12.361 |
| Net Income Ratio
| 0 | -49.025 | -3.593 | -9.371 | -1.945 | -1.413 | -2.111 | -0.25 | -0.863 |
| EPS
| -8.62 | -0.022 | -0.016 | -0.011 | -0.013 | -0.019 | -0.069 | -0.019 | -0.049 |
| EPS Diluted
| -8.62 | -0.022 | -0.016 | -0.011 | -0.013 | -0.019 | -0.069 | -0.019 | -0.048 |
| EBITDA
| -17,892.376 | -17.873 | -11.512 | -7.002 | -4.187 | -7.873 | -16.567 | -2.885 | -10.551 |
| EBITDA Ratio
| 0 | -41.308 | -2.754 | -10.062 | -2.027 | -1.523 | -1.884 | -0.139 | -0.736 |